Related Experiment Video
Updated: May 2, 2026
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Is the 2009 FIGO staging system really valuable for stage I endometrial cancer?
F Atalay1, K Cetinkaya1, A Bacinoglu1
1Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Purpose:
The aim of this study was to compare the survival predictive values of the 1988 and 2009 FIGO staging systems for the staging of patients with early-stage endometrioid type endometrial cancer.
Materials And Methods:
Two hundred twenty-four patients treated for endometrial cancer from 1996 to 2006 at Ankara Oncology Education and Research Hospital were staged according to the two staging systems. Early-stage patients with a histological diagnosis of endometrioid adenocarcinoma were included in the study. The Kaplan-Meier method was used for survival analysis.
Results:
The charts of 224 patients treated for endometrial cancer were retrospectively evaluated. The five-year overall survival (OS) for Stage IA and IB cases was 100% (n = 19) and 96.2% (n = 79), respectively, with no significant difference between the OS values (p = 0.126) with the FIGO 1988 system and 96,4% (n = 112) and 87.5% (n = 48), respectively with a statistically significant difference (p = 0.05) with the FIGO 2009 system.
Conclusion:
The authors found that the survival prognostic value of the 2009 FIGO staging system was more effective than the 1988 FIGO staging system for cases with early-stage endometrioid type endometrial cancer.
